Management of Obstructive Colon Tumors in Istanbul
- Conditions
- Colon CancerTumor ObstructionEmergenciesQuality of Life
- Registration Number
- NCT05424939
- Lead Sponsor
- Istanbul Medipol University Hospital
- Brief Summary
The aim of this study is to evaluate the outcome of obstructive colon cancer surgery in terms of days-to-starting adjuvant therapy and quality of life.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 500
- Acute intestinal obstruction due to colon cancer either preoperatively or intraoperatively detected
- Clinical findings of obstruction (Abdominal distention and pain, nausea or vomiting, and absence of bowel movements) confirmed by abdominal x-ray or CT
- Benign diseases
- Emergency surgery due to bleeding, perforation and other non-obstructive situations
- Recurrent colon tumors
- Rectal cancer
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time-to-starting chemotherapy 1 year Surgical procedures will be compared in terms of days-to-first chemotherapy
- Secondary Outcome Measures
Name Time Method Morbidity 3 months 90-day morbidity
Colorectal cancer-specific quality of life (EORTC QLQ - CR29) at 1 year 1 year The European Organization for Research and Treatment of Cancer, Quality of Life Questionnaire-Colorectal Cancer (EORTC QLQ-CR29) scale will be recorded preoperatively and at 12 months. Surgical procedures will be compared in terms of improvement in EORTC QLQ-CR29 scores.
Mortality 3 months 90-day mortality
Trial Locations
- Locations (2)
Medipol University Bahcelievler Hospital
🇹🇷Istanbul, Turkey
Medipol Mega Hospital
🇹🇷Istanbul, Turkey